Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular AMD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02698566
What this trial is testing

A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)

Who this might be right for
Macular Edema
Genentech, Inc. 35
Large-scale testing (Phase 3)UnknownNCT00148551
What this trial is testing

Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

Who this might be right for
Age-Related Macular Degeneration
Canadian Retinal Trials Group 120
Large-scale testing (Phase 3)Ended earlyNCT04049266
What this trial is testing

Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.

Who this might be right for
Wet Macular Degeneration
Kodiak Sciences Inc 559
Post-approval studies (Phase 4)Study completedNCT02246829
What this trial is testing

Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START

Who this might be right for
Neovascular Age-related Macular Degeneration of All Subtypes
University Hospital, Bordeaux 50
Not applicableStudy completedNCT04169802
What this trial is testing

Study Evaluating Retinal Health Monitoring System Visual Acuity Module.

Who this might be right for
Age Related Macular Degeneration
Kubota Vision Inc. 25
Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Post-approval studies (Phase 4)Study completedNCT02843490
What this trial is testing

Functional and Structural Outcomes in Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Johannes Gutenberg University Mainz 71
Early research (Phase 1)Study completedNCT02530918
What this trial is testing

Study of DS-7080a for the Treatment of Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Daiichi Sankyo 56
Not applicableNot Yet RecruitingNCT07328776
What this trial is testing

AI vs. Physician for Anti-VEGF Decision-Making: An RCT

Who this might be right for
DMERetinal Vein Occlusion (RVO)Neovascular (Wet) Age-Related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 200
Early research (Phase 1)Study completedNCT01024998
What this trial is testing

Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular DegenerationAge-Related MaculopathiesAge-Related Maculopathy+7 more
Genzyme, a Sanofi Company 19
Testing effectiveness (Phase 2)Study completedNCT00426998
What this trial is testing

Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
Retinal Consultants Medical Group 30
Not applicableNot Yet RecruitingNCT07567898
What this trial is testing

Effectiveness of Multidisciplinary Protocolised Interventions on IVT Non-adherence Rates

Who this might be right for
Diabetic Macular EdemaNeovascular (Wet) Age-Related Macular DegenerationIntravitreal Injection
Singapore Eye Research Institute 200
Not applicableStudy completedNCT02304068
What this trial is testing

The Accuracy of Home Monitoring for Acute Macular Degeneration (AMD) Disease Activity

Who this might be right for
Acute Macular Degeneration
The Leeds Teaching Hospitals NHS Trust
Testing effectiveness (Phase 2)Study completedNCT00373659
What this trial is testing

An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Miami 40
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Post-approval studies (Phase 4)Ended earlyNCT05473715
What this trial is testing

Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bayer 3
Not applicableStudy completedNCT06699914
What this trial is testing

Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 438
Not applicableNot Yet RecruitingNCT07744204
What this trial is testing

LEAP Strategy for Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)Wet Macular Degeneration
Chinese PLA General Hospital 240
Large-scale testing (Phase 3)Study completedNCT04777201
What this trial is testing

Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Hoffmann-La Roche 1,036
Post-approval studies (Phase 4)UnknownNCT02802657
What this trial is testing

Efficacy and Safety of "Treat-and-Extend" Regimen Versus "Pro Re Nata" of Conbercept in Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Xiaodong Sun 141
Next Page